Beyond acute SARS-CoV-2 infection: A new challenge for Internal Medicine.
Beyond acute SARS-CoV-2 infection: A new challenge for Internal Medicine.
复制标题
DOI：
10.1016/j.rceng.2021.09.004
复制
发表时间：
2022-03
影响因子：
2.9
通讯作者：
Medrano-Ortega FJ
中科院分区：
文献类型：
--
作者：
Martín-Garrido I;Medrano-Ortega FJ
新型SARS-CoV-2冠状病毒感染已达到大流行的程度，全球死亡人数非常高。尽管科学界付出了艰苦的努力来解决这种疾病的急性期，以及通过在创纪录的时间内开发疫苗来预防，但仍然存在另一个重要的主力：理解和治疗急性期后的持续症状，即所谓的持久性COVID-19综合征或持续性COVID。这些持续的表现影响几个器官和系统，可能取决于病毒的致病机制和患者的病理生理反应。在这一流行病爆发一年后，迫切需要采取全面办法处理这一局势。
Infection with the new SARS-CoV-2 coronavirus has reached pandemic proportions, with a very high death toll worldwide. Despite the scientific community's strenuous efforts to address this disease in its acute phase, as well as in prevention through the development of vaccines in record time, there remains another important workhorse: understanding and treating the persistence of symptoms beyond the acute phase, the so-called protracted COVID-19 syndrome or persistent COVID. These persistent manifestations affect several organs and systems and may depend on both the pathogenic mechanisms of the virus and the pathophysiological response of the patient. One year after the onset of this pandemic, there is an urgent need to address this situation from a comprehensive approach.